Literature DB >> 11256531

Symptomatic atrial arrhythmias in hemodialysis patients.

N Ansari1, T Manis, D A Feinfeld.   

Abstract

BACKGROUND/AIMS: Cardiac arrhythmias are frequent in hemodialysis patients and can interrupt treatment. However, the frequency and risk factors have remained unclear because previous reports of arrhythmias in dialysis patients have usually been continuous-monitoring studies that looked at all cardiac ectopy regardless of its seriousness.
METHODS: We reviewed retrospectively only symptomatic atrial arrhythmias in a population of 106 maintenance hemodialysis patients over three years, in order to estimate their actual frequency and any risk factors.
RESULTS: Ten patients, seven men and three women, required treatment for atrial arrhythmias (9.4%): four for supraventricular tachycardia, three for atrial flutter, and three for atrial fibrillation. Their mean age was 53.7 +/- 6.1 years; five of them were < or = 40 years. Seven arrhythmias were new, three were recurrences. All but one occurred between 3 and 4 hours of hemodialysis, and dialysis had to be stopped in nine instances. There was no pattern of hypotensive episodes preceding the arrhythmias. Mean serum K+ drawn at the time of the arrhythmias was 3.8 +/- 0.2 mEq/L. Mean plasma intact parathormone was 1128 +/- 417 pg/mL, compared to 454 +/- 58 pg/mL for our entire hemodialysis population (p = .0036). Subsequent echocardiograms showed abnormalities in 9/10 patients: five had left ventricular hypertrophy, six had left atrial enlargement, five had valvular lesions (four mitral regurgitation; one aortic incompetence), and three had ejection fractions <50%. There were four deaths in these patients over the next 14 months, but probably only one was cardiac.
CONCLUSIONS: Serious atrial arrhythmias are common in a hemodialysis population. Risk factors for symptomatic atrial arrhythmias in hemodialysis patients may include hyperparathyroidism and echocardiographic findings of chamber enlargement, valvular lesions, or ventricular dysfunction.

Entities:  

Mesh:

Year:  2001        PMID: 11256531     DOI: 10.1081/jdi-100001285

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  10 in total

1.  Relation of renal function to risk for incident atrial fibrillation in women.

Authors:  Roopinder K Sandhu; Tobias Kurth; David Conen; Nancy R Cook; Paul M Ridker; Christine M Albert
Journal:  Am J Cardiol       Date:  2011-11-17       Impact factor: 2.778

2.  Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).

Authors:  Elsayed Z Soliman; Ronald J Prineas; Alan S Go; Dawei Xie; James P Lash; Mahboob Rahman; Akinlolu Ojo; Val L Teal; Nancy G Jensvold; Nancy L Robinson; Daniel L Dries; Lydia Bazzano; Emile R Mohler; Jackson T Wright; Harold I Feldman
Journal:  Am Heart J       Date:  2010-06       Impact factor: 4.749

3.  Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.

Authors:  Ting-Tse Lin; Yao-Hsu Yang; Min-Tsun Liao; Chia-Ti Tsai; Juey J Hwang; Fu-Tien Chiang; Pau-Chung Chen; Jiunn-Lee Lin; Lian-Yu Lin
Journal:  Kidney Int       Date:  2015-03-25       Impact factor: 10.612

4.  Increased P wave dispersion and maximum P wave duration after hemodialysis.

Authors:  Ugur K Tezcan; Basri Amasyali; Ilknur Can; Kudret Aytemir; Sedat Köse; Izzet Yavuz; Hurkan Kursaklioglu; Ersoy Işik; Ertan Demirtaş; Ali Oto
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-01       Impact factor: 1.468

Review 5.  Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease.

Authors:  Yazan Khouri; Tiona Stephens; Gloria Ayuba; Hazim AlAmeri; Nour Juratli; Peter A McCullough
Journal:  J Atr Fibrillation       Date:  2015-04-30

6.  Comparison of the CHADS2, CHA2DS2-VASc and R2CHADS2 Scores in Japanese Patients with Non-valvular Paroxysmal Atrial Fibrillation Not Receiving Anticoagulation Therapy.

Authors:  Reisuke Yoshizawa; Takashi Komatsu; Fusanori Kunugita; Mahito Ozawa; Shingen Ohwada; Yoshihiro Satoh; Yoshihiro Morino; Motoyuki Nakamura
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

7.  CARDIAC DISORDER IN HEMODIALYSIS: BENEFITS OF CHINESE HERBS.

Authors:  ZhongQing Lü; Min Sun; ChunJie Hu; YanQing Tong
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-09-29

Review 8.  Multitargeted interventions to reduce dialysis-induced systemic stress.

Authors:  Bernard Canaud; Melanie P Stephens; Milind Nikam; Michael Etter; Allan Collins
Journal:  Clin Kidney J       Date:  2021-12-27

9.  Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality.

Authors:  Kevin C Abbott; Fernando C Trespalacios; Allen J Taylor; Lawrence Y Agodoa
Journal:  BMC Nephrol       Date:  2003-01-24       Impact factor: 2.388

10.  Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan.

Authors:  Cheng-Huang Shen; Cai-Mei Zheng; Kee-Thai Kiu; Hsin-An Chen; Chia-Chang Wu; Kuo-Cheng Lu; Yung-Ho Hsu; Yuh-Feng Lin; Yuan-Hung Wang
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.